Mostrar el registro sencillo del ítem

dc.contributor.authorGalvez-Fernandez, Marta
dc.contributor.authorRodriguez-Hernandez, Zulema
dc.contributor.authorGrau-Perez, Maria
dc.contributor.authorChaves, F. Javier
dc.contributor.authorGarcia-Garcia, Ana Barbara
dc.contributor.authorAmigo, Nuria
dc.contributor.authorMonleon, Daniel
dc.contributor.authorGarcia-Barrera, Tamara
dc.contributor.authorGomez-Ariza, Jose L.
dc.contributor.authorBriongos-Figuero, Laisa S.
dc.contributor.authorPerez-Castrillon, Jose L.
dc.contributor.authorRedon, Josep
dc.contributor.authorTellez-Plaza, Maria
dc.contributor.authorMartin-Escudero, Juan C.
dc.date.accessioned2024-10-28T12:44:28Z
dc.date.available2024-10-28T12:44:28Z
dc.date.issued2023
dc.identifier.citationFree Radic Biol Med. 2023 Jan;194:52-61.es
dc.identifier.issn0891-5849es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/70983
dc.description.abstractBackground The potential joint influence of metabolites on bone fragility has been rarely evaluated. We assessed the association of plasma metabolic patterns with bone fragility endpoints (primarily, incident osteoporosis-related bone fractures, and, secondarily, bone mineral density BMD) in the Hortega Study participants. Redox balance plays a key role in bone metabolism. We also assessed differential associations in participant subgroups by redox-related metal exposure levels and candidate genetic variants. Material and methods In 467 participants older than 50 years from the Hortega Study, a representative sample from a region in Spain, we estimated metabolic principal components (mPC) for 54 plasma metabolites from NMR-spectrometry. Metals biomarkers were measured in plasma by AAS and in urine by HPLC-ICPMS. Redox-related SNPs (N = 341) were measured by oligo-ligation assay. Results The prospective association with incident bone fractures was inverse for mPC1 (non-essential and essential amino acids, including branched-chain, and bacterial co-metabolites, including isobutyrate, trimethylamines and phenylpropionate, versus fatty acids and VLDL) and mPC4 (HDL), but positive for mPC2 (essential amino acids, including aromatic, and bacterial co-metabolites, including isopropanol and methanol). Findings from BMD models were consistent. Participants with decreased selenium and increased antimony, arsenic and, suggestively, cadmium exposures showed higher mPC2-associated bone fractures risk. Genetic variants annotated to 19 genes, with the strongest evidence for NCF4, NOX4 and XDH, showed differential metabolic-related bone fractures risk. Conclusions Metabolic patterns reflecting amino acids, microbiota co-metabolism and lipid metabolism were associated with bone fragility endpoints. Carriers of redox-related variants may benefit from metabolic interventions to prevent the consequences of bone fragility depending on their antimony, arsenic, selenium, and, possibly, cadmium, exposure levels.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherElsevieres
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.subject.classificationMetabolomics Bone mineral density Osteoporosis-related bone fractures Candidate genes Metals Redoxes
dc.titleMetabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Studyes
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1016/j.freeradbiomed.2022.11.007es
dc.identifier.publicationfirstpage52es
dc.identifier.publicationlastpage61es
dc.identifier.publicationtitleFree Radical Biology and Medicinees
dc.identifier.publicationvolume194es
dc.peerreviewedSIes
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem